High-density lipoproteins neutralize C-reactive protein proinflammatory activity

被引:139
作者
Wadham, C
Albanese, N
Roberts, J
Wang, LJ
Bagley, CJ
Gamble, JR
Rye, KA
Barter, PJ
Vadas, MA
Xia, P
机构
[1] Inst Med & Vet Sci, Div Human Immunol, Hanson Inst, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Adelaide, SA, Australia
[3] Heart Res Inst, Lipid Res Grp, Camperdown, NSW, Australia
关键词
lipoproteins; protein; inflammation; atherosclerosis;
D O I
10.1161/01.CIR.0000127419.45975.26
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-C-reactive protein (CRP), a well-recognized marker of atherosclerosis, has recently been suggested to have a direct proinflammatory effect. The constitutive expression of low levels of CRP in normal plasma suggests the likelihood that a natural factor exists to neutralize the effect of CRP. This factor(s) has not yet been identified. Method and Results - The proinflammatory effect of CRP was measured by the induction of inflammatory adhesion molecules in human umbilical vein endothelial cells (HUVECs). We show that CRP significantly induced upregulation of adhesion molecules in both protein and mRNA levels. The CRP-induced expression of these inflammatory adhesion molecules was completely suppressed when the cells were preincubated with a physiological concentration ( 1 mg/mL apolipoprotein A-I) of HDLs derived from human plasma (native HDL) or reconstituted HDL (rHDL) at a very low concentration (0.01 mg/mL apolipoprotein A-I). A novel mechanism of HDL inhibition is likely to operate, because ( 1) rHDL was 100 times more potent than native HDL, ( 2) preincubation with HDL and its sustained presence were obligatory, and ( 3) oxidized 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine was the fundamental active component. Conclusions - The CRP-induced upregulation of inflammatory adhesion molecules in HUVECs was completely prevented by HDL via their oxidized phospholipid components.
引用
收藏
页码:2116 / 2122
页数:7
相关论文
共 28 条
[21]  
Pasceri V, 2001, CIRCULATION, V103, P2531
[22]   Novel risk factors for systemic atherosclerosis - A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease [J].
Ridker, PM ;
Stampfer, MJ ;
Rifai, N .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2481-2485
[23]   C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women [J].
Ridker, PM ;
Hennekens, CH ;
Buring, JE ;
Rifai, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (12) :836-843
[24]   Anti-inflammatory mechanisms in the vascular wall [J].
Tedgui, A ;
Mallat, Z .
CIRCULATION RESEARCH, 2001, 88 (09) :877-887
[25]   Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells [J].
Venugopal, SK ;
Devaraj, S ;
Yuhanna, I ;
Shaul, P ;
Jialal, I .
CIRCULATION, 2002, 106 (12) :1439-1441
[26]   A self-fulfilling prophecy - C-reactive protein attenuates nitric oxide production and inhibits angiogenesis [J].
Verma, S ;
Wang, CH ;
Li, SH ;
Dumont, AS ;
Fedak, PWM ;
Badiwala, MV ;
Dhillon, B ;
Weisel, RD ;
Li, RK ;
Mickle, DAG ;
Stewart, DJ .
CIRCULATION, 2002, 106 (08) :913-919
[27]   FACTORS INFLUENCING ENDOTHELIAL CELL-PROLIFERATION INVITRO [J].
WALL, RT ;
HARKER, LA ;
QUADRACCI, LJ ;
STRIKER, GE .
JOURNAL OF CELLULAR PHYSIOLOGY, 1978, 96 (02) :203-213
[28]   High density lipoproteins (HDL) interrupt the sphingosine kinase signaling pathway - A possible mechanism for protection against atherosclerosis by HDL [J].
Xia, P ;
Vadas, MA ;
Rye, KA ;
Barter, PJ ;
Gamble, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (46) :33143-33147